Increased epicardial adipose tissue volume correlates with cardiac sympathetic denervation in patients with heart failure

Circulation Research

Volumn 118, Issue 8, 2016, Pages 1244-1253

  Parisi, Valentina ^a   Rengo, Giuseppe ^a,b   Perrone Filardi, Pasquale ^a   Pagano, Gennaro ^a   Femminella, Grazia Daniela ^a   Paolillo, Stefania ^c   Petraglia, Laura ^a   Gambino, Giuseppina ^a,b   Caruso, Aurelio ^a,d   Grimaldi, Maria Gabriella ^d   Baldascino, Francesco ^d   Nolano, Maria ^b   Elia, Andrea ^b   Cannavo, Alessandro ^a   De Bellis, Antonio ^d   Coscioni, Enrico ^e   Pellegrino, Teresa ^a,f   Cuocolo, Alberto ^a   Ferrara, Nicola ^a   Leosco, Dario ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b IRCCS   (Italy)

^c IRCCS SDN   (Italy)

^d Casa di Cura San Michele ^*  (Italy)

^e S Giovanni di Dio   (Italy)

^f CNR   (Italy)

Author keywords

echocardiography; epicardial adipose tissue; heart failure; MIBG; nuclear radiology; sympathetic nervous system

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; ADRENALIN; CATECHOLAMINE; DOPAMINE BETA MONOOXYGENASE; MESSENGER RNA; NORADRENALIN; PHENYLETHANOLAMINE N METHYLTRANSFERASE; TYROSINE 3 MONOOXYGENASE;

ADIPOSE TISSUE; ADRENERGIC ACTIVITY; ADULT; ARTICLE; CONTROLLED STUDY; DENERVATION; DIABETES MELLITUS; DYSLIPIDEMIA; ECHOCARDIOGRAPHY; EPICARDIAL ADIPOSE TISSUE; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE VARIABILITY; HEART SURGERY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MYOCARDIAL PERFUSION IMAGING; PARASYMPATHETIC TONE; PREDICTIVE VALUE; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SMOKING; SUBCUTANEOUS FAT; SYMPATHETIC DENERVATION; SYMPATHETIC INNERVATION; SYMPATHETIC NERVE CELL; SYSTOLIC HEART FAILURE; THICKNESS; ADRENERGIC NERVE; AGED; ECHOGRAPHY; GATED SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY; HEART FAILURE; INNERVATION; MIDDLE AGED; ORGAN SIZE; PERICARDIUM; PROCEDURES; SCINTISCANNING;

ADIPOSE TISSUE; ADRENERGIC FIBERS; AGED; CARDIAC-GATED SINGLE-PHOTON EMISSION COMPUTER-ASSISTED TOMOGRAPHY; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; ORGAN SIZE; PERICARDIUM;

EID: 84959297596     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.115.307765     Document Type: Article

References (50)

1. Lymperopoulos A, Rengo G, Koch WJ, Adrenergic nervous system in heart failure: pathophysiology and therapy. Circ Res 2013 113 739 753. doi: 10.1161/CIRCRESAHA.113.300308
2. Rengo G, Lymperopoulos A, Koch WJ, Future G protein-coupled receptor targets for treatment of heart failure. Curr Treat Options Cardiovasc Med 2009 11 328 338
3. Triposkiadis F, Karayannis G, Giamouzis G, Skoularigis J, Louridas G, Butler J, The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications. J Am Coll Cardiol 2009 54 1747 1762. doi: 10.1016/j.jacc.2009.05.015
4. Iaccarino G, Barbato E, Cipolletta E, De Amicis V, Margulies KB, Leosco D, Trimarco B, Koch WJ, Elevated myocardial and lymphocyte GRK2 expression and activity in human heart failure. Eur Heart J 2005 26 1752 1758. doi: 10.1093/eurheartj/ehi429
5. Rengo G, Perrone-Filardi P, Femminella GD, Liccardo D, Zincarelli C, de Lucia C, Pagano G, Marsico F, Lymperopoulos A, Leosco D, Targeting the β-adrenergic receptor system through G-protein-coupled receptor kinase 2: a new paradigm for therapy and prognostic evaluation in heart failure: from bench to bedside. Circ Heart Fail 2012 5 385 391. doi: 10.1161/CIRCHEARTFAILURE.112.966895
6. Rengo G, Lymperopoulos A, Leosco D, Koch WJ, GRK2 as a novel gene therapy target in heart failure. J Mol Cell Cardiol 2011 50 785 792. doi: 10.1016/j.yjmcc.2010.08.014
7. Böhm M, La Rosée K, Schwinger RH, Erdmann E, Evidence for reduction of norepinephrine uptake sites in the failing human heart. J Am Coll Cardiol 1995 25 146 153
8. Ungerer M, Hartmann F, Karoglan M, Chlistalla A, Ziegler S, Richardt G, Overbeck M, Meisner H, Schömig A, Schwaiger M, Regional in vivo and in vitro characterization of autonomic innervation in cardiomyopathic human heart. Circulation 1998 97 174 180
9. Backs J, Haunstetter A, Gerber SH, Metz J, Borst MM, Strasser RH, Kübler W, Haass M, The neuronal norepinephrine transporter in experimental heart failure: evidence for a posttranscriptional downregulation. J Mol Cell Cardiol 2001 33 461 472. doi: 10.1006/jmcc.2000.1319
10. Paolillo S, Rengo G, Pagano G, Impact of diabetes on cardiac sympathetic innervation in patients with heart failure: a 123I meta-iodobenzylguanidine (123I MIBG) scintigraphic study. Diabetes Care 2013 36 2395 2401. doi: 10.2337/dc12-2147
11. Jacobson AF, Senior R, Cerqueira MD, Wong ND, Thomas GS, Lopez VA, Agostini D, Weiland F, Chandna H, Narula J, ADMIRE-HF Investigators ADMIRE-HF Investigators Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study. J Am Coll Cardiol 2010 55 2212 2221. doi: 10.1016/j.jacc.2010.01.014
12. Mardon K, Montagne O, Elbaz N, Malek Z, Syrota A, Dubois-Randé JL, Meignan M, Merlet P, Uptake-1 carrier downregulates in parallel with the beta-adrenergic receptor desensitization in rat hearts chronically exposed to high levels of circulating norepinephrine: implications for cardiac neuroimaging in human cardiomyopathies. J Nucl Med 2003 44 1459 1466
13. Bristow MR, Ginsburg R, Minobe W, Cubicciotti RS, Sageman WS, Lurie K, Billingham ME, Harrison DC, Stinson EB, Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. N Engl J Med 1982 307 205 211. doi: 10.1056/NEJM198207223070401
14. Kimura K, Kanazawa H, Ieda M, Kawaguchi-Manabe H, Miyake Y, Yagi T, Arai T, Sano M, Fukuda K, Norepinephrine-induced nerve growth factor depletion causes cardiac sympathetic denervation in severe heart failure. Auton Neurosci 2010 156 27 35. doi: 10.1016/j.autneu.2010.02.005
15. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S, Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1995 1 1155 1161
16. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL, Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996 334 292 295. doi: 10.1056/NEJM199602013340503
17. Perrone-Filardi P, Paolillo S, Costanzo P, Savarese G, Trimarco B, Bonow RO, The role of metabolic syndrome in heart failure. Eur Heart J 2015 36 2630 2634. doi: 10.1093/eurheartj/ehv350
18. Vargovic P, Ukropec J, Laukova M, Cleary S, Manz B, Pacak K, Kvetnansky R, Adipocytes as a new source of catecholamine production. FEBS Lett 2011 585 2279 2284. doi: 10.1016/j.febslet.2011.06.001
19. Mazurek T, Zhang L, Zalewski A, Mannion JD, Diehl JT, Arafat H, Sarov-Blat L, O'Brien S, Keiper EA, Johnson AG, Martin J, Goldstein BJ, Shi Y, Human epicardial adipose tissue is a source of inflammatory mediators. Circulation 2003 108 2460 2466. doi: 10.1161/01.CIR.0000099542.57313.C5
20. Iacobellis G, Corradi D, Sharma AM, Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart. Nat Clin Pract Cardiovasc Med 2005 2 536 543. doi: 10.1038/ncpcardio0319
21. Baker AR, Silva NF, Quinn DW, Harte AL, Pagano D, Bonser RS, Kumar S, McTernan PG, Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease. Cardiovasc Diabetol 2006 5 1. doi: 10.1186/1475-2840-5-1
22. Chaldakov GN, Stankulov IS, Aloe L, Subepicardial adipose tissue in human coronary atherosclerosis: another neglected phenomenon. Atherosclerosis 2001 154 237 238
23. Eroglu S, Sade LE, Yildirir A, Bal U, Ozbicer S, Ozgul AS, Bozbas H, Aydinalp A, Muderrisoglu H, Epicardial adipose tissue thickness by echocardiography is a marker for the presence and severity of coronary artery disease. Nutr Metab Cardiovasc Dis 2009 19 211 217. doi: 10.1016/j.numecd.2008.05.002
24. Iacobellis G, Ribaudo MC, Zappaterreno A, Iannucci CV, Leonetti F, Relation between epicardial adipose tissue and left ventricular mass. Am J Cardiol 2004 94 1084 1087. doi: 10.1016/j.amjcard.2004.06.075
25. Fontes-Carvalho R, Fontes-Oliveira M, Sampaio F, Mancio J, Bettencourt N, Teixeira M, Rocha Gonçalves F, Gama V, Leite-Moreira A, Influence of epicardial and visceral fat on left ventricular diastolic and systolic functions in patients after myocardial infarction. Am J Cardiol 2014 114 1663 1669. doi: 10.1016/j.amjcard.2014.08.037
26. Parisi V, Rengo G, Pagano G, D'Esposito V, Passaretti F, Caruso A, Grimaldi MG, Lonobile T, Baldascino F, De Bellis A, Formisano P, Ferrara N, Leosco D, Epicardial adipose tissue has an increased thickness and is a source of inflammatory mediators in patients with calcific aortic stenosis. Int J Cardiol 2015 186 167 169. doi: 10.1016/j.ijcard.2015.03.201
27. Iacobellis G, Willens HJ, Echocardiographic epicardial fat: a review of research and clinical applications. J Am Soc Echocardiogr 2009 22 1311 1319; quiz 1417. doi: 10.1016/j.echo.2009.10.013
28. Flotats A, Carrió I, Agostini D, Le Guludec D, Marcassa C, Schäfers M, Schaffers M, Somsen GA, Unlu M, Verberne HJ, EANM Cardiovascular Committee; European Council of Nuclear Cardiology EANM Cardiovascular Committee; European Council of Nuclear Cardiology Proposal for standardization of 123I-metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM Cardiovascular Committee and the European Council of Nuclear Cardiology. Eur J Nucl Med Mol Imaging 2010 37 1802 1812. doi: 10.1007/s00259-010-1491-4
29. Pellegrino T, Petretta M, De Luca S, Paolillo S, Boemio A, Carotenuto R, Petretta MP, di Nuzzo C, Perrone-Filardi P, Cuocolo A, Observer reproducibility of results from a low-dose 123I-metaiodobenzylguanidine cardiac imaging protocol in patients with heart failure. Eur J Nucl Med Mol Imaging 2013 40 1549 1557. doi: 10.1007/s00259-013-2461-4
30. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS, American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 2002 105 539 542
31. Balcioǧlu AS, Çiçek D, Akinci S, Eldem HO, Bal UA, Okyay K, Müderrisoǧlu H, Arrhythmogenic evidence for epicardial adipose tissue: heart rate variability and turbulence are influenced by epicardial fat thickness. Pacing Clin Electrophysiol 2015 38 99 106. doi: 10.1111/pace.12512
32. Zhou Q, Zhang L, Wang K, Xu X, Ji M, Zhang F, Wang H, Hou Y, Effect of interconnection between cervical vagus trunk, epicardial fat pad on sinus node function, and atrial fibrillation. Pacing Clin Electrophysiol 2014 37 356 363. doi: 10.1111/pace.12265
33. Lin YK, Chen YC, Chen JH, Chen SA, Chen YJ, Adipocytes modulate the electrophysiology of atrial myocytes: implications in obesity-induced atrial fibrillation. Basic Res Cardiol 2012 107 293. doi: 10.1007/s00395-012-0293-1
34. Chen PS, Turker I, Epicardial adipose tissue and neural mechanisms of atrial fibrillation. Circ Arrhythm Electrophysiol 2012 5 618 620. doi: 10.1161/CIRCEP.112.974956
35. Ardell JL, The cardiac neuronal hierarchy and susceptibility to arrhythmias. Heart Rhythm 2011 8 590 591. doi: 10.1016/j.hrthm.2010.12.019
36. Jiang YH, Jiang P, Yang JL, Ma DF, Lin HQ, Su WG, Wang Z, Li X, Cardiac dysregulation and myocardial injury in a 6-hydroxydopamine-induced rat model of sympathetic denervation. PLoS One 2015 10 e0133971. doi: 10.1371/journal.pone.0133971
37. White IA, Gordon J, Balkan W, Hare JM, Sympathetic reinnervation is required for mammalian cardiac regeneration. Circ Res 2015 117 990 994. doi: 10.1161/CIRCRESAHA.115.307465
38. Corradi D, Maestri R, Callegari S, Pastori P, Goldoni M, Luong TV, Bordi C, The ventricular epicardial fat is related to the myocardial mass in normal, ischemic and hypertrophic hearts. Cardiovasc Pathol 2004 13 313 316. doi: 10.1016/j.carpath.2004.08.005
39. Kuwahara T, Hamada M, Hiwada K, Direct evidence of impaired cardiac sympathetic innervation in essential hypertensive patients with left ventricular hypertrophy. J Nucl Med 1998 39 1486 1491
40. Slavin BG, Ballard KW, Morphological studies on the adrenergic innervation of white adipose tissue. Anat Rec 1978 191 377 389. doi: 10.1002/ar.1091910310
41. Bartness TJ, Bamshad M, Innervation of mammalian white adipose tissue: implications for the regulation of total body fat. Am J Physiol 1998 275 R1399 R1411
42. Bartness TJ, Song CK, Sympathetic and sensory innervation of white adipose tissue. J Lipid Res 2007 48 1655 1672
43. Berlan M, Lafontan M, The alpha 2-adrenergic receptor of human fat cells: comparative study of alpha 2-adrenergic radioligand binding and biological response. J Physiol (Paris) 1982 78 279 287
44. Lafontan M, Berlan M, Fat cell alpha 2-adrenoceptors: the regulation of fat cell function and lipolysis. Endocr Rev 1995 16 716 738. doi: 10.1210/edrv-16-6-716
45. Lafontan M, Langin D, Lipolysis and lipid mobilization in human adipose tissue. Prog Lipid Res 2009 48 275 297. doi: 10.1016/j.plipres.2009.05.001
46. Giordano A, Frontini A, Murano I, Tonello C, Marino MA, Carruba MO, Nisoli E, Cinti S, Regional-dependent increase of sympathetic innervation in rat white adipose tissue during prolonged fasting. J Histochem Cytochem 2005 53 679 687. doi: 10.1369/jhc.4A6566.2005
47. Bowers RR, Festuccia WT, Song CK, Shi H, Migliorini RH, Bartness TJ, Sympathetic innervation of white adipose tissue and its regulation of fat cell number. Am J Physiol Regul Integr Comp Physiol 2004 286 R1167 R1175. doi: 10.1152/ajpregu.00558.2003
48. Zhu XH, He QL, Lin ZH, Effects of catecholamines on human preadipocyte proliferation and differentiation. Zhonghua Zheng Xing Wai Ke Za Zhi 2003 19 282 284
49. Kvetnansky R, Sabban EL, Palkovits M, Catecholaminergic systems in stress: structural and molecular genetic approaches. Physiol Rev 2009 89 535 606. doi: 10.1152/physrev.00042.2006
50. Iacobellis G, Willens HJ, Barbaro G, Sharma AM, Threshold values of high-risk echocardiographic epicardial fat thickness. Obesity (Silver Spring) 2008 16 887 892. doi: 10.1038/oby.2008.6